This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,113.22, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a performance period through January 2, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 4/1/25, 10:56 AM